Gastroesophageal Reflux Disease (GERD)

Last Updated: November 15, 2023

Gastroesophageal Reflux Disease (GERD) is a common, chronic condition characterized by discomfort due to the backflow of stomach contents into the esophagus (or throat) through a dysfunctional esophageal sphincter. GERD can be managed with lifestyle modifications or treated with acid-suppressing drugs or surgery.

Gastroesophageal Reflux Disease (GERD) falls under theGut Healthcategory.

What is GERD?

Gastroesophageal reflux disease (GERD) is a chronic condition in which the stomach contents reflux into the esophagus due to a dysfunctional esophageal sphincter; it affects up to 1 in 6 people globally. Although it is not life-threatening, GERD can significantly affect quality of life and may increase the risk of esophageal cancer if untreated, but it can be managed through lifestyle changes, medications, and surgery.

What are the main signs and symptoms of GERD?

The main signs and symptoms of gastroesophageal reflux disease (GERD) include tooth erosion, chest pain, chronic cough, laryngitis, asthma, and heartburn. Additionally, GERD is associated with an increased risk of nonalcoholic fatty liver disease and Barrett’s esophagus, which can lead to esophageal cancer.

How is GERD diagnosed?

Gastroesophageal reflux disease (GERD) can be diagnosed primarily through symptoms, but it may require referral to a gastroenterologist for further testing. This testing can include upper endoscopy, pH measurement of the esophagus, or a barium swallow to observe the esophageal sphincter.

What are some of the main medical treatments for GERD?

Gastroesophageal reflux disease (GERD) is initially treated with lifestyle modifications, and if those are insufficient, acid-suppressing medications like proton pump inhibitors (PPIs) or H2 blockers may be prescribed, though long-term use of PPIs raises concerns about gut health and other risks. In some cases, surgery may be necessary to repair a hiatal hernia or strengthen the esophageal sphincter.

Have any supplements been studied for GERD?

Several supplements — such as prebiotics, fermented soy, xylitol-malic acid tablets, rose oil, and traditional Chinese medicinal herbs — have been studied for gastroesophageal reflux disease (GERD) and have shown mixed results, with some improvement in quality of life and heartburn relief. However, further research is necessary to validate these initial findings.

How could diet affect GERD?

Diet can affect gastroesophageal reflux disease (GERD); though improvements are usually mild, following traditional advice such as eating smaller meals, avoiding late meals, and limiting triggers like spicy, acidic, or fatty foods can help. The low-FODMAP diet may also be beneficial.

Are there any other treatments for GERD?

Certain breathing exercises, particularly diaphragmatic breathing, may help increase the pressure of the lower esophageal sphincter and potentially alleviate reflux. However, further research is necessary to confirm their effectiveness in reducing the symptoms of gastroesophageal reflux disease (though improvements are usually mild) and improving quality of life.

What causes GERD?

Gastroesophageal reflux disease (GERD) is primarily caused by the relaxation of the lower esophageal sphincter or increased pressure, which can result from factors like delayed stomach emptying, hiatal hernia, or visceral hypersensitivity. Risk factors include age over 50, smoking, use of nonsteroidal anti-inflammatory drugs, obesity, low socioeconomic status, alcohol consumption, and sleep deprivation, whereas H. pylori infection and stomach acidity alone are not confirmed causes.

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Gastroesophageal Reflux Disease (GERD)
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Update History
2023-11-15 00:30:04

Additonal FAQ added

minor

We added a FAQ about the long-term repercussions of the use of proton pump inhibitors and other simlar medications.

Written By

Reviewed By

References
  1. ^Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford ACGlobal prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.Gut.(2018-03)
  2. ^National Institute of Diabetes and Digestive and Kidney Diseases
  3. ^Zhao Y, Li Y, Hu J, Wang X, Ren M, Lu G, Lu X, Zhang D, He SThe Effect of Helicobacter pylori Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies.Dig Dis.(2020)
  4. ^National Institute of Diabetes and Digestive and Kidney Diseases
  5. ^Barium Swallow
  6. ^Hojo M, Asaoka D, Shimada Y, Nojiri S, Nagahara AStrategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial.BMC Gastroenterol.(2022-Jan-15)
  7. ^Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ, Dijkstra G, Franke L, Xavier RJ, Jonkers D, Wijmenga C, Weersma RK, Zhernakova AProton pump inhibitors affect the gut microbiome.Gut.(2016-May)
  8. ^Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, Sutter JL, Welter D, Ley RE, Bell JT, Spector TD, Steves CJProton pump inhibitors alter the composition of the gut microbiota.Gut.(2016-May)
  9. ^Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AVAssociation between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.Clin Gastroenterol Hepatol.(2012-Mar)
  10. ^Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TARisk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.PLoS One.(2015)
  11. ^Suehiro M, Dannals RF, Scheffel U, Stathis M, Wilson AA, Ravert HT, Villemagne VL, Sanchez-Roa PM, Wagner HNIn vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.J Nucl Med.(1990-Dec)
  12. ^Insogna KLThe effect of proton pump-inhibiting drugs on mineral metabolism.Am J Gastroenterol.(2009-Mar)
  13. ^Si XB, Huo LY, Bi DY, Lan Y, Zhang SComparative Efficacy of Antidepressants for Symptoms Remission of Gastroesophageal Reflux: A Bayesian Network Meta-analysis of Randomized Controlled Trials.Turk J Gastroenterol.(2021-Oct)
  14. ^Xie P, Yan J, Ye L, Wang C, Li Y, Chen Y, Li GEfficacy of different endoscopic treatments in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis.Surg Endosc.(2021-04)
  15. ^Zhuang QJ, Tan ND, Chen SF, Zhang MY, Xiao YLMagnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta-analysis.J Dig Dis.(2021-Dec)
  16. ^Beckett JM, Singh NK, Phillips J, Kalpurath K, Taylor K, Stanley RA, Eri RDAnti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study.Nutrients.(2020-Jun-18)
  17. ^Sánchez-Blanco I, Rodríguez-Téllez M, Corcuera-Flores JR, González-Blanco C, Torres-Lagares D, Serrera-Figallo MÁ, Machuca-Portillo GEffectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.Med Oral Patol Oral Cir Bucal.(2020-Nov-01)
  18. ^Fatani A, Vaher K, Rivero-Mendoza D, Alabasi K, Dahl WJFermented soy supplementation improves indicators of quality of life: a randomized, placebo-controlled, double-blind trial in adults experiencing heartburn.BMC Res Notes.(2020-Aug-03)
  19. ^Zhang J, Che H, Zhang B, Zhang C, Zhou B, Ji H, Xie J, Shi X, Li X, Wang F, Tang XJianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study.Phytomedicine.(2021-Jul-15)
  20. ^Adel Mehraban MS, Shirzad M, Ahmadian-Attari MM, Shakeri R, Taghizadeh Kashani LM, Tabarrai M, Shirbeigi LEffect of rose oil on Gastroesophageal Reflux Disease in comparison with omeprazole: A double-blind controlled trial.Complement Ther Clin Pract.(2021-May)
  21. ^Li Z, Tao L, Zhang SS, Sun XH, Chen SN, Wu JModified Xiaochaihu Decoction for gastroesophageal reflux disease: A randomized double-simulation controlled trial.World J Gastroenterol.(2021-Jul-28)
  22. ^Abenavoli L, Luigiano C, Pendlimari R, Fagoonee S, Pellicano REfficacy and tolerability of a novel galactomannan-based formulation for symptomatic treatment of gastroesophageal reflux disease: a randomized, double-blind, placebo-controlled study.Eur Rev Med Pharmacol Sci.(2021-06)
  23. ^Rivière P, Vauquelin B, Rolland E, Melchior C, Roman S, Bruley des Varannes S, Mion F, Gourcerol G, Sacher-Huvelin S, Zerbib FLow FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: An open-labeled randomized trial.Neurogastroenterol Motil.(2021-09)
  24. ^Kaijie Qiu, Jie Wang, Baiwen Chen, Haibiao Wang, Chenyang MaThe effect of breathing exercises on patients with GERD: a meta-analysisAnn Palliat Med.(2020 Mar)
  25. ^Mou WL, Feng MY, Hu LHEradication of Helicobacter Pylori Infections and GERD: A systematic review and meta-analysis.Turk J Gastroenterol.(2020-12)
  26. ^Ergun P, Kipcak S, Dettmar PW, Fisher J, Woodcock AD, Bor SPepsin and pH of Gastric Juice in Patients With Gastrointestinal Reflux Disease and Subgroups.J Clin Gastroenterol.(2022-Jul-01)
  27. ^Januszewicz W, Hartley J, Waldock W, Roberts G, Alias B, Hobson A, Wernisch L, di Pietro MEndoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.United European Gastroenterol J.(2019-Dec-01)
  28. ^Roman S, Serraj I, Damon H, Mion FCorrelation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.Neurogastroenterol Motil.(2007-Jul)
  29. ^Pan J, Cen L, Chen W, Yu C, Li Y, Shen ZAlcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis.Alcohol Alcohol.(2019-Jan-01)
  30. ^Yamasaki T, Quan SF, Fass RThe effect of sleep deficiency on esophageal acid exposure of healthy controls and patients with gastroesophageal reflux disease.Neurogastroenterol Motil.(2019-12)
  31. ^NIHEating, Diet, & Nutrition for GER and GERD
  32. ^Badillo R, Francis DDiagnosis and treatment of gastroesophageal reflux disease.World J Gastrointest Pharmacol Ther.(2014-Aug-06)
  33. ^Ness-Jensen E, Hveem K, El-Serag H, Lagergren JLifestyle Intervention in Gastroesophageal Reflux Disease.Clin Gastroenterol Hepatol.(2016-Feb)
  34. ^NIHSymptoms & Causes of GER & GERD
  35. ^Haruma K, Kinoshita Y, Sakamoto S, Sanada K, Hiroi S, Miwa HLifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study.Intern Med.(2015)
  36. ^Jansson C, Wallander MA, Johansson S, Johnsen R, Hveem KStressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway.Scand J Gastroenterol.(2010)
  37. ^Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, Dalton CB, Salley ANThe relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors.Am J Gastroenterol.(1993-Jan)
  38. ^Fass R, Naliboff BD, Fass SS, Peleg N, Wendel C, Malagon IB, Mayer EAThe effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease.Gastroenterology.(2008-Mar)
  39. ^Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, Karamanolis GRisk factors for gastroesophageal reflux disease and analysis of genetic contributors.World J Clin Cases.(2018-Aug-16)
  40. ^Lembo A, Zaman M, Jones M, Talley NJInfluence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.Aliment Pharmacol Ther.(2007-Jun-01)
  41. ^
  42. ^de Vries DR, ter Linde JJ, van Herwaarden MA, Smout AJ, Samsom MGastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3).Am J Gastroenterol.(2009-Feb)
Examine Database References
  1. Inflammation - Andersen LP, Holck S, Kupcinskas L, Kiudelis G, Jonaitis L, Janciauskas D, Permin H, Wadström TGastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthinFEMS Immunol Med Microbiol.(2007 Jul)
  2. Lower Esophageal Pressure - Kandil TS, Mousa AA, El-Gendy AA, Abbas AMThe potential therapeutic effect of melatonin in Gastro-Esophageal Reflux DiseaseBMC Gastroenterol.(2010 Jan 18)
  3. Gastric Emptying Rate - Hu ML, Rayner CK, Wu KL, Chuah SK, Tai WC, Chou YP, Chiu YC, Chiu KW, Hu THEffect of ginger on gastric motility and symptoms of functional dyspepsiaWorld J Gastroenterol.(2011 Jan 7)